GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.940
-0.070 (-2.33%)
At close: Oct 31, 2024, 4:00 PM
2.820
-0.120 (-4.08%)
After-hours: Oct 31, 2024, 6:13 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $6.57 million as of October 31, 2024. Its market cap has decreased by -32.97% in one year.
Market Cap
6.57M
Enterprise Value
-2.52M
1-Year Change
-32.97%
Ranking
Category
Stock Price
$2.94
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $6.57M, a decrease of -92.10%. That is a compound annual growth rate of -31.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 6.70M | -36.79% |
Dec 29, 2023 | 10.60M | -63.19% |
Dec 30, 2022 | 28.80M | -69.13% |
Dec 31, 2021 | 93.30M | 181.02% |
Dec 31, 2020 | 33.20M | 503.64% |
Dec 31, 2019 | 5.50M | -83.13% |
Dec 31, 2018 | 32.60M | -60.82% |
Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aptose Biosciences | 7.16M |
Ontrak | 7.15M |
Alzamend Neuro | 6.98M |
Organovo Holdings | 6.95M |
Forte Biosciences | 6.78M |
Check-Cap | 6.67M |
Xenetic Biosciences | 6.60M |
Mainz Biomed | 6.52M |